University Health Network, Toronto: Liver Neoplasms trials
The registry lists 11 Liver Neoplasms studies with University Health Network, Toronto as lead sponsor. 1 are open to participants now and 0 have results posted.
Phase 1 3Phase 2 6No phase 4(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- MR Guidance for Liver and PancreasRecruitingNCT03582189
- Study of TBI-1301 (NY-ESO-1 Specific TCR Gene Transduced Autologous T Lymphocytes) in Patients With Solid TumorsActive, not recruitingNCT02869217Phase 1
- A Study of Pancreatic Cancer in Xenografts From Liver MetastasesCompletedNCT01774643
- A Study of Perioperative Chemotherapy Plus Panitumumab in Patients With Colorectal Cancer Liver MetastasesCompletedNCT01260415Phase 2
- Comparison of Primovist-enhanced MRI, Diffusion Weighted MRI and Multidetector CT of Colorectal Liver MetastasesCompletedNCT01255007Not applicable
- Palliative Radiotherapy (RT) for Liver Metastases (Mets) and Hepatocellular Carcinoma (HCC)(COLD 4)CompletedNCT00923897Phase 2
- Stereotactic Body Radiation Therapy (SBRT) in Liver Metastasis (COLD 3)CompletedNCT00914615Phase 2
- Sorafenib-RT Treatment for Liver Metastasis (SLIM)CompletedNCT00892424Phase 1/2
- Comparison of Triphasic CT, PET and MR Tumour With Pathological Findings in Colorectal Cancer Liver MetastasesCompletedNCT00242086Not applicable
- Stereotactic Radiotherapy (SRT) Liver (COLD 1)CompletedNCT00152906Phase 1/2
- Oblimersen and Doxorubicin in Treating Patients With Advanced Hepatocellular Carcinoma (Liver Cancer)CompletedNCT00047229Phase 2